Early Detection of Fabry Disease

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Fabry Disease
Interventions
OTHER

No intervention

This is non-interventional study.

Trial Locations (3)

55131

Universitätsmedizin Mainz Villa Metabolica Zentrum für Kinder- und Jugendmedizin, Mainz

91054

Universitätsklinikum Erlangen Kinder- und Jugendklinik, Erlangen

Universitätsklinikum Erlangen Neurologische Klinik, Erlangen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05106764 - Early Detection of Fabry Disease | Biotech Hunter | Biotech Hunter